Zydus Cadila gets tentative USFDA nod to market anti-cancer drug

Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules. Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Palbociclib Capsules in the strengths of 75 mg, 100 mg, and 125 mg, Zydus Cadila, part of the Cadila Healthcare group, said in a regulatory filing.

To Contact Insurance and Investment Expert
Thanks for reading. Please Share, Comment, Like the post And Follow, Subscribe Insurance and Investment News
from Source